Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-02-01
2011-02-01
Fay, Zohreh A (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
Reexamination Certificate
active
07879824
ABSTRACT:
The invention relates to a method of preventing and treating diseases and conditions associated with allergies, autoimmunity, the adhesion cascade, the metastatic cascade or the coronary cascade comprising administering (i) at least one complex carbohydrate as the sole active ingredient, or (ii) at least one pharmaceutical composition which comprises as an active ingredient a pharmacologically effective amount of at least one low purity or cosmetic grade complex carbohydrate selected from the group consisting of oligosaccharides, sialylated oligosaccharides, polysaccharides and glycosaminoglycans, and an effective amount of at least one transdermal or transmucosal carrier in an amount effective to deliver the complex carbohydrate into the blood stream.
REFERENCES:
patent: 3895107 (1975-07-01), Morrison
patent: 4141973 (1979-02-01), Balazs
patent: 4148893 (1979-04-01), Smith
patent: 4248861 (1981-02-01), Schutt
patent: 4303676 (1981-12-01), Balazs
patent: 4353896 (1982-10-01), Levy
patent: 4440777 (1984-04-01), Zupan
patent: 4463016 (1984-07-01), Burgess
patent: 4474763 (1984-10-01), Lubowe
patent: 4521411 (1985-06-01), Koloff
patent: 4564521 (1986-01-01), Altadonna
patent: 4585656 (1986-04-01), Rosenthal et al.
patent: 4707354 (1987-11-01), Garlen et al.
patent: 4708873 (1987-11-01), Schulte
patent: 4736024 (1988-04-01), Della Valle et al.
patent: 4782046 (1988-11-01), Brown et al.
patent: 4797402 (1989-01-01), Dorsey
patent: 4800197 (1989-01-01), Kowcz et al.
patent: 4808576 (1989-02-01), Schultz et al.
patent: 4847078 (1989-07-01), Sheppard et al.
patent: 4883664 (1989-11-01), Sharkey
patent: 4895727 (1990-01-01), Allen
patent: 4900550 (1990-02-01), Lowry
patent: 4917890 (1990-04-01), McAnalley
patent: 4933183 (1990-06-01), Sharma et al.
patent: 4933184 (1990-06-01), Tsuk
patent: 4973473 (1990-11-01), Schneider et al.
patent: 5009890 (1991-04-01), Dipippo
patent: 5013726 (1991-05-01), Ivy et al.
patent: 5028429 (1991-07-01), Gochenouer
patent: 5073366 (1991-12-01), Beck
patent: 5079260 (1992-01-01), Weitzberg et al.
patent: 5082656 (1992-01-01), Hui et al.
patent: 5096709 (1992-03-01), Vandersloot
patent: 5106622 (1992-04-01), Sherwood et al.
patent: 5166331 (1992-11-01), Della Valle et al.
patent: 5179086 (1993-01-01), Flender
patent: 5215759 (1993-06-01), Mausner
patent: 5223257 (1993-06-01), Arora
patent: 5266318 (1993-11-01), Taylor-McCord
patent: 5308838 (1994-05-01), McAnalley et al.
patent: 5331012 (1994-07-01), Riddick et al.
patent: 5350774 (1994-09-01), Palou
patent: 5362497 (1994-11-01), Yamada et al.
patent: 5460821 (1995-10-01), Masiz
patent: 5559103 (1996-09-01), Gaeta et al.
patent: 5604200 (1997-02-01), Taylor-McCord
patent: 5773425 (1998-06-01), McAnalley et al.
patent: 5888984 (1999-03-01), Brown
patent: 5929050 (1999-07-01), Petito
patent: 5965152 (1999-10-01), Galin et al.
patent: 6083933 (2000-07-01), Hahn
patent: 6391864 (2002-05-01), Stone
patent: 6432929 (2002-08-01), Stone
patent: 6875753 (2005-04-01), Pilarski
patent: 6924273 (2005-08-01), Pierce
patent: 2002/0068718 (2002-06-01), Pierce
patent: 2 156 013 (1997-02-01), None
patent: 19520575 (1996-12-01), None
patent: 195 47 105 (1997-06-01), None
patent: 0 130 550 (1985-01-01), None
patent: 0 254 845 (1988-02-01), None
patent: 0 444 492 (1991-09-01), None
patent: 0 497 162 (1992-08-01), None
patent: 0 509 120 (1992-10-01), None
patent: 0 704 216 (1996-04-01), None
patent: 0 795 560 (1997-09-01), None
patent: 0 852 236 (1998-07-01), None
patent: 26 74749 (1992-10-01), None
patent: 59-163307 (1984-09-01), None
patent: S62-77308 (1987-04-01), None
patent: 63-008309 (1988-01-01), None
patent: 01 186824 (1989-07-01), None
patent: 04 041431 (1992-02-01), None
patent: 5-66149 (1993-03-01), None
patent: 06 107550 (1994-04-01), None
patent: 9-262057 (1997-10-01), None
patent: WO-87/05517 (1987-09-01), None
patent: WO-88/01280 (1988-02-01), None
patent: WO 90/00058 (1990-01-01), None
patent: WO-91/13624 (1991-09-01), None
patent: WO 92 11780 (1992-07-01), None
patent: WO 92/18546 (1992-10-01), None
patent: WO 92/22585 (1992-12-01), None
patent: WO 93/05075 (1993-03-01), None
patent: WO 93/09766 (1993-05-01), None
patent: WO 93 09766 (1993-05-01), None
patent: WO 95/23605 (1995-09-01), None
patent: WO 95 31177 (1995-11-01), None
patent: WO 95/34286 (1995-12-01), None
patent: WO 96/05845 (1996-02-01), None
patent: WO-96/06622 (1996-03-01), None
patent: WO 96/32492 (1996-10-01), None
patent: WO 97/25051 (1997-07-01), None
patent: WO 97/33592 (1997-09-01), None
patent: WO 97/40841 (1997-11-01), None
patent: WO 97/45435 (1997-12-01), None
patent: WO 98/06730 (1998-02-01), None
patent: WO 98/08854 (1998-03-01), None
patent: WO-00/08061 (2000-02-01), None
David C. Steinberg,Cosmetic Technology. Mucopolysaccharides for cosmetics, (Feb. 1982), pp. 41-44.
Article: Essense Oils, 2 pages.
Chemistry 470- “Industrial Chemistry”, Spring 2004, Internet, 6 pages.
Srivas R. Srinivas,“Atlas of Essential Oils”, 2 pages.
D. Kobayshi et al.,Pharmaceutical Research, vol. 11, No. 1, 1994, Analysis of the Combined Effect of 1-Menthol and Ethanol as Skin Permeation Enhancers Based on a Two-Layer Skin Model (article), Dec. 4, 1992—accepted Jun. 22, 1993; pp. 96-103.
Hans Schaefer et al.;Skin Barrier(article), 3 pages, Karger.
Claire Parisel et al., Interactions of heparin with human skin cells: Binding, location, and transdermal penetration (article); Nov. 5, 2002, Accepted Mar. 4, 2003; pp. 517-523; 2003Wiley Periodicals, Inc.
Pankaj Karande et al.,Nature Biotechnology-Advance Online Publication, Discovery of transdermal penetration enhancers by high-throughput screening (article), published online (Jan. 4, 2004), pp. 1-6.
Gregory M. Glenn et al.,Naturevol. 391, Skin immunization made possible by cholera toxin (article), Feb. 26, 1998), 1 page.
Gregory M. Glenn et al.,Cutting Edge, Cutting Edge: Transcutaneous Immunization with Cholera Toxin Protects Mice Against Lethal Mucosal Toxin Challenge (article), pp. 3211-3214.
Tanya Scharton-Kersten et al.,Infection and Immunity, vol. 68, No. 9, Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins, Subunits, and Unrelated Adjuvants (Sep. 2000), pp. 5306-5313.
Gregor Cevc et al.,Biochimica et Biophysica Acta, vol. 1368, (1998), Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalism skin, pp. 201-215.
Raghavachari et al.,Journal of Pharmaceutical Sciences, vol. 91, No. 3, (Mar. 2002), Targeted Gene Delivery to Skin Cells In Vivo: A Comparative Study of Liposomes and Polymers as Delivery Vehicles, 9 pages.
Marc Cohen et al.,The Journal of Rheumatology, vol. 30, No. 3, (2003) A Randomized, Double Blind, Placebo Controlled Trial of a Topical Cream Containing Glucosamine Sulfate, Chondroitin Sulfate, and Camphor for Osteoarthritis of the Knee, pp. 523-528.
Marie Curie and the Science of Radioactivity—Research Breakthroughs (1897-1904) 2 pages; 2000-2004American Institute of Physics.
Naturopathic Laboratories International, Inc., Plaintiff, v.Dermal Research Laboratories, Inc., Defendant, Complaint, 8 pages, U.S. District Court for the Western District of Missouri Western Division.
Naturopathic Laboratories International, Inc., Plaintiff, v.Dermal Research Laboratories, Inc., Defendant, Dermal Research Laboratories, Inc.'s Answer and Counterclaim to Naturopathic Laboratories International Inc.'s Complaint, 14 pages, U.S. District Court for the Western District of Missouri Western Division.
Naturopathic Laboratories International, Inc., Plaintiff, v.Dermal Research Laboratories, Inc., Defendant, Reply of Naturopathic Laboratories International, Inc., to Counterclaim of Dermal Research Laboratories, Inc., 6 pages, U.S. District Court for the Western District of Missouri Western Division.
Naturopathic Laboratories International, Inc., Plaintiff, v.Dermal Research Laboratories, Inc., Defendant, Plaintiff Naturopathic Laboratories, International, Inc.'s Response to Defendant's First Set of Interrogatories, 14 pages, U.S. District Court for
Brown Harold G.
Brown Karen K.
Cooper Carol A.
Birch & Stewart Kolasch & Birch, LLP
Dermal Research Laboratories, Inc.
Fay Zohreh A
LandOfFree
Methods of preventing or treating diseases and conditions... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of preventing or treating diseases and conditions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of preventing or treating diseases and conditions... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2642905